Medicine Description vanzapro 1 mg
vanzapro 1 mg ampoules is a medication that belongs to the class of fourth-generation cephalosporins, specifically cefepime, which exhibits antimicrobial activity against a wide range of gram-positive and gram-negative bacteria. Its mechanism of action involves the inhibition of bacterial cell wall synthesis. Cefepime binds to penicillin-binding proteins (PBPs) located in the bacterial cell wall, leading to the disruption of cell wall construction. This disruption ultimately causes lysis and death of susceptible bacteria, making cefepime effective in treating various infections. Furthermore, cefepime is resistant to many beta-lactamases, allowing it to retain activity against certain resistant strains. It is well-absorbed and achieves high concentrations in the bloodstream and tissues, enhancing its therapeutic efficacy against serious infections.
Indications and Uses of vanzapro 1 mg ampoules
- Complicated intra-abdominal infections
- Complicated urinary tract infections
- Pneumonia caused by susceptible organisms
- Febrile neutropenia
- Skin and soft tissue infections
Side Effects of vanzapro 1 mg ampoules
- Nausea and vomiting
- Diarrhea
- Rash
- Increased liver enzymes
- Headache
- Allergic reactions
- Seizures (rarely)
Storage and Handling
Store vanzapro 1 mg ampoules at controlled room temperature, away from light and moisture. Do not freeze. Keep out of reach of children.
Patient Advice and Precautions
It is crucial to complete the entire course of Vanzapro as prescribed, even if symptoms improve, to prevent the development of resistance. Patients should be monitored for signs of an allergic reaction, especially if they have a history of penicillin allergies. Adequate hydration should be maintained, particularly in cases of renal impairment. Advise patients to report any unusual side effects promptly to their healthcare provider.